Immune dysfunction prior to and during vaccination in multiple myeloma: a case study based on COVID-19 - Poll - MDSpire

Immune dysfunction prior to and during vaccination in multiple myeloma: a case study based on COVID-19

  • By

  • Esperanza Martín-Sánchez

  • Luis-Esteban Tamariz-Amador

  • Camila Guerrero

  • Anastasiia Zherniakova

  • Aintzane Zabaleta

  • Catarina Maia

  • Laura Blanco

  • Diego Alignani

  • Maria-Antonia Fortuño

  • Carlos Grande

  • Andrea Manubens

  • Jose-Maria Arguiñano

  • Clara Gomez

  • Ernesto Perez-Persona

  • Iñigo Olazabal

  • Itziar Oiartzabal

  • Carlos Panizo

  • Felipe Prosper

  • Jesus F. San-Miguel

  • Paula Rodriguez-Otero

  • Bruno Paiva

  • July 10, 2024

  • 0 min

Share

Original Source(s)

Immune dysfunction prior to and during vaccination in multiple myeloma: a case study based on COVID-19

  • by Esperanza Martín-Sánchez, Luis-Esteban Tamariz-Amador, Camila Guerrero, Anastasiia Zherniakova, Aintzane Zabaleta, Catarina Maia, Laura Blanco, Diego Alignani, Maria-Antonia Fortuño, Carlos Grande, Andrea Manubens, Jose-Maria Arguiñano, Clara Gomez, Ernesto Perez-Persona, Iñigo Olazabal, Itziar Oiartzabal, Carlos Panizo, Felipe Prosper, Jesus F. San-Miguel, Paula Rodriguez-Otero, Bruno Paiva

  • July 10, 2024

Related Content

Proteomic and Metabolomic Profiling via Mass Spectrometry in Multiple Myeloma: A Comprehensive Review of Prognostic Biomarkers and Monitoring of Minimal Residual Disease

Prognostic Impact of Early Disease Progression and Early Mortality in Patients with Multiple Myeloma: A Real-World Cohort Study

Safety, immunogenicity, and long COVID outcomes following inactivated COVID-19 vaccine boosters in elderly Chinese: a prospective cohort study